The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Bay­er flush­es mon­ey in­to the Nordics with $303M down pay­ment on new Finnish plant, ex­pan­sion

4 years ago

Re­call re­port: An­oth­er drug­mak­er is pulling its ver­sion of met­formin off shelves af­ter a car­cino­gen scare

4 years ago
FDA+

As it ex­pands its foot­print, Mod­er­na reach­es deal to com­mer­cial­ize Covid-19 vac­cine dos­es in Mid­dle East

4 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: BioN­Tech an­nounces plans to pro­duce mR­NA vac­cines in Africa; As­traZeneca de­liv­er­ies from Thai­land de­layed

4 years ago
Coronavirus

An API firm with a his­to­ry of J&J fund­ing scores a ma­jor loan to ad­vance its port­fo­lio

4 years ago
R&D

With its con­tro­ver­sial ad­u­canum­ab ap­proval in hand, Bio­gen gears up for a quick US roll­out

4 years ago
R&D

A Wash­ing­ton CMO is dou­bling its man­u­fac­tur­ing ca­pac­i­ty, less than 5 years in­to its ex­is­tence

4 years ago

Ex­e­lead inks deal to man­u­fac­ture lipid nanopar­ti­cles for Pfiz­er/BioN­Tech vac­cine

4 years ago
Outsourcing

No­var­tis cuts jobs at Swiss plant as a UK fa­cil­i­ty sits in a hold­ing pat­tern with 200 po­si­tions on the line — re­ports

4 years ago
Outsourcing

Ju­bi­lant Hol­lis­ter­Sti­er plots out ex­pan­sion at WA ster­ile in­jecta­bles plant amid work on Covid-19 vac­cines

4 years ago
Outsourcing

AGC adds an­oth­er ma­jor Covid-19 vac­cine mak­er to the client list with BioN­Tech pact for plas­mid DNA

4 years ago
R&D

Af­ter a noose was found at NC plant, Mer­ck launch­es in­ter­nal in­ves­ti­ga­tion while de­cry­ing racist acts

4 years ago

Just months af­ter SPAC re­verse merg­er, Point Bio­phar­ma ups the ante at In­di­anapo­lis man­u­fac­tur­ing site

4 years ago
R&D

As com­pa­nies dump mon­ey in­to man­u­fac­tur­ing, where will they find the trained work­ers to staff the lines?

4 years ago

Aa­van­tiBio lands man­u­fac­tur­ing part­ner in Friedre­ich's Atax­ia pro­gram; NC Re­search Tri­an­gle lands an­oth­er CD­MO

4 years ago
R&D

A Bel­gian man­u­fac­tur­er looks to pit its freeze dry­ing process against mR­NA — and be­yond

4 years ago
R&D

As the mR­NA push con­tin­ues, Sam­sung will ex­pand its drug sub­stance man­u­fac­tur­ing at South Ko­re­an hub

4 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Af­ter Emer­gent dis­as­ter, As­traZeneca in talks to move to Catal­ent plant — re­port; Sinopharm says it has ca­pac­i­ty to pro­duce 5B vac­cines

4 years ago
R&D

Mod­er­na bags an­oth­er US CD­MO to help with fill-fin­ish work for its vac­cine amid boost­er push

4 years ago
Outsourcing

The man­u­fac­tur­ing hold at Emer­gen­t's Bal­ti­more Bayview plant could be com­ing to an end — re­port

4 years ago
Coronavirus

CD­MO Ter­gus cuts the rib­bon on Durham plant, lat­est in a line of com­pa­nies pack­ing in­to the emerg­ing NC hub

5 years ago

Bio­gen adds key man­u­fac­tur­ing plant to its po­ten­tial­ly quixot­ic ad­u­canum­ab launch plan

5 years ago

Q&A: Amid an M&A flur­ry at Charles Riv­er, long­time ex­ec Bir­git Gir­shick dis­cuss­es how Covid-19 has changed the game

5 years ago
People

Covid-19 man­u­fac­tur­ing roundup: WHO let­ter out­lines re­boot of IP shar­ing pro­gram; In­dia backs down on do­mes­ti­cal­ly-pro­duced vac­cine tri­al

5 years ago
Coronavirus
First page Previous page 70717273747576 Next page Last page
A service from the Financial Times